Healthy Term Infants Fed Milk-Based Formulas
- Conditions
- Infants
- Interventions
- Other: Standard Milk-based Formula Containing CarotenoidOther: Investigational Milk-based Formula Containing Carotenoid
- Registration Number
- NCT02069522
- Lead Sponsor
- Abbott Nutrition
- Brief Summary
This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 91
- Infant is in good health
- Infant is a singleton from a full term birth with a gestational age of 37-42 weeks
- Infant's birth weight was > 2490 g (~5 lbs 8 oz)
- Infant is between 14 and 28 days of age
- Parent(s) confirm intention to feed their infant the study product(s) as the sole source of nutrition for the duration of the study
- Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and ARA supplements, solid foods/juices to their infant from enrollment through the duration of the study
- An adverse maternal, fetal or infant medical history that has potential for effects on tolerance, growth, and/or development.
- Infants using medications (including OTC), home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Standard Milk-based Formula Containing Carotenoid Standard Milk-based Formula Containing Carotenoid milk-based ready to feed infant formula Investigational Milk-based Formula Containing Carotenoid Investigational Milk-based Formula Containing Carotenoid investigational milk-based ready to feed infant formula
- Primary Outcome Measures
Name Time Method Carotenoid Concentration Change from Baseline to end of Study Period A (~21 Days) Plasma sample
- Secondary Outcome Measures
Name Time Method Carotenoid Concentration Change from Baseline to end Study Periods A (~21 Days) and B (~21 Days) Plasma sample
Trial Locations
- Locations (6)
Midwest Children's Health Research Institute
🇺🇸Lincoln, Nebraska, United States
MetroHealth Medical Center
🇺🇸Cleveland, Ohio, United States
Northpoint Pediatrics
🇺🇸Indianapolis, Indiana, United States
Institute of Clinical Research
🇺🇸Mayfield Heights, Ohio, United States
Tuscon Medical Center
🇺🇸Tuscon, Arizona, United States
Dayton Clinical Research
🇺🇸Dayton, Ohio, United States